| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | Beetham Thomas W. | EVP &Chief Legal Officer | Sell | 29,589 | $25.37 | $750,678.08 | -91.2% | |
| Jul 1, 2020 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 1,179 | $137.29 | $161,864.91 | -6.7% | |
| Jul 1, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $22.27 | $11,135.60 | -0.6% | |
| Jul 1, 2020 | BMY Bristol Myers Squibb Co | Celgene Corp /de/ | 10% Owner | Buy | 108,108 | $92.50 | $9,999,990.00 | +1.6% | |
| Jul 1, 2020 | ZTS Zoetis Inc. | Trawicki Roman48 | Executive Vice President | Sell | 5,499 | $137.29 | $754,957.71 | -79.5% | |
| Jun 30, 2020 | RMTI Rockwell Medical, Inc. | Richmond David S. | 10% Owner, See Footnotes 1 And 2 | Buy | 24,681 | $1.93 | $47,563.35 | +4.1% | |
| Jun 30, 2020 | TAK Takeda Pharmaceutical Co Ltd | Shire Human Genetic Therapies, Inc. | 10% Owner | Sell | 6,824,992 | $20.68 | $141,140,834.56 | -100% | |
| Jun 30, 2020 | NVS Novartis AG | Novartis Bioventures Ltd | Former 10% Owner | Buy | 125,000 | $17.00 | $2,125,000.00 | +11.8% | |
| Jun 30, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 166,832 | $163.20 | $27,227,760.40 | - | |
| Jun 30, 2020 | JNJ Johnson & Johnson | Johnson & Johnson59 | 10% Owner | Buy | 725,000 | $17.00 | $12,325,000.00 | +24.6% | |
| Jun 29, 2020 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 6,000 | $49.47 | $296,800.00 | -12.0% | |
| Jun 29, 2020 | PCRX Pacira Biosciences, Inc. | Laranjeira Charles Anthony61 | SVP, Technical Operations | Sell | 60,101 | $50.27 | $3,021,314.41 | -45.8% | |
| Jun 29, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 11,431 | $163.39 | $1,867,759.95 | - | |
| Jun 29, 2020 | BUDZ Weed, Inc. | Kwestel Elliot | Director Of Weed Israel Ltd. | Sell | 17,889 | $0.31 | $5,559.45 | -4.8% | |
| Jun 26, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 31,737 | $163.01 | $5,173,403.94 | - | |
| Jun 26, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 31,737 | $163.01 | $5,173,403.94 | - | |
| Jun 23, 2020 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 5,000 | $130.00 | $650,000.00 | -16.1% | |
| Jun 23, 2020 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 5,000 | $130.00 | $650,000.00 | -34.7% | |
| Jun 19, 2020 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 35,000 | $5.58 | $195,401.50 | +1.4% | |
| Jun 19, 2020 | NVS Novartis AG | Novartis Bioventures Ltd | Former 10% Owner | Sell | 1,002,212 | $8.25 | $8,268,960.00 | -14.4% | |
| Jun 18, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 53,770 | $161.54 | $8,686,046.06 | - | |
| Jun 18, 2020 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 350,000 | $8.20 | $2,869,708.37 | -2.6% | |
| Jun 18, 2020 | GTBIF Green Thumb Industries Inc. | Kadens Peter A. | 10% Owner | Sell | 969,900 | $7.79 | $7,551,933.00 | -20.3% | |
| Jun 17, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 161,230 | $161.38 | $26,019,469.34 | - | |
| Jun 17, 2020 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 19,386 | $9.21 | $178,610.14 | -0.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.